Tech Company Financing Transactions

Fractyl Laboratories Funding Round

Private investors, Bessemer Venture Partners and Deerfield Capital participated in a $44 million Series D funding round for Fractyl Laboratories. The round was announced on 12/1/2017.

Transaction Overview

Company Name
Fractyl Laboratories
Announced On
12/1/2017
Transaction Type
Venture Equity
Amount
$44,000,000
Round
Series D
Investors

private investors (Lead Investor)

Bessemer Venture Partners (Christopher Gabrieli)

Deerfield Capital (Avi Kometz)

Domain Associates (Brian Dovey)

Emergent Medical Partners

General Catalyst Partners (Hemant Taneja)

GV (Krishna Yeshwant)

IDO Investments

Mithril Capital Management (Ajay Royan)

True Ventures

Proceeds Purpose
Proceeds from the financing will be used towards continued development of Fractyl's Revita DMR technology for patients with type 2 diabetes, including support for the ongoing Revita-2 randomized clinical study.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
17 Hartwell Ave.
Lexington, MA 02421
USA
Phone
Undisclosed
Website
www.fractyl.com
Email Address
[email protected]
Overview
Fractyl is developing Revita DMR, a same-day, minimally invasive procedure to treat two highly prevalent metabolic diseases: type 2 diabetes and NAFLD/NASH. The Revita DMR procedure harnesses breakthrough insights in the role of the duodenum in causing insulin resistance and metabolic diseases.
Profile
Fractyl Laboratories LinkedIn Company Profile
Social Media
Fractyl Laboratories Company Twitter Account
Company News
Fractyl Laboratories News
Facebook
Fractyl Laboratories on Facebook
YouTube
Fractyl Laboratories on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Harith Rajagopalan
  Harith Rajagopalan LinkedIn Profile  Harith Rajagopalan Twitter Account  Harith Rajagopalan News  Harith Rajagopalan on Facebook
Chief Financial Officer
Lisa Davidson
  Lisa Davidson LinkedIn Profile  Lisa Davidson Twitter Account  Lisa Davidson News  Lisa Davidson on Facebook
Chief Medical Officer
Juan Lopez-Talavera
  Juan Lopez-Talavera LinkedIn Profile  Juan Lopez-Talavera Twitter Account  Juan Lopez-Talavera News  Juan Lopez-Talavera on Facebook
President
Jay Caplan
  Jay Caplan LinkedIn Profile  Jay Caplan Twitter Account  Jay Caplan News  Jay Caplan on Facebook
Vice President
Kelly White
  Kelly White LinkedIn Profile  Kelly White Twitter Account  Kelly White News  Kelly White on Facebook
VP - Bus. Development
Margaret Borys
  Margaret Borys LinkedIn Profile  Margaret Borys Twitter Account  Margaret Borys News  Margaret Borys on Facebook
VP - Manufacturing
Len Rosberg
  Len Rosberg LinkedIn Profile  Len Rosberg Twitter Account  Len Rosberg News  Len Rosberg on Facebook
VP - Regulatory Affairs
Jon Fitzgerald
  Jon Fitzgerald LinkedIn Profile  Jon Fitzgerald Twitter Account  Jon Fitzgerald News  Jon Fitzgerald on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/1/2017: Switchboard Live venture capital transaction
Next: 12/1/2017: H2O.ai venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.